VC  Dementia Discovery Fund

https://theddfund.com/





     Office Locations:

c/o SV Health Investors
201 Washington Street, Suite 3900
Boston, MA 02108
Phone: 617-367-8100

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    The Dementia Discovery Fund is a specialist venture capital fund that invests in novel science to create meaningful new medicines for dementia whilst delivering an attractive return for the fund investors. The fundraising far exceeded its initial target of $200 million making it the first and largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer's disease. DDF has mechanisms in place to fund up to $1M for hypothesis testing with the aim of company spin-out on achievement of agreed milestones. For companies closer to the clinic, DDF will invest or co-invest larger amounts in order to progress through candidate selection and early clinical trials. The DDF makes early stage venture capital investments to develop novel disease-modifying therapeutics for all forms of dementia. The fund is managed by SV Health and was formed through the collaboration of leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda), the UK Department of Health and Social Care and the charity Alzheimer's Research UK (ARUK). In addition to the $60 million investment from AARP and commitments from new investors UnitedHealth Group, Aegon, Quest Diagnostics, British Patient Capital and several others, the DDF has a broad and influential investor base, which includes Bill Gates, seven leading pharmaceutical companies, Woodford Investment Management via Woodford Patient Capital Trust (WPCT), the NFL Players Association, the UK's Department of Health and Social Care and ARUK.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Houman Ashrafian Partner
    Kate Bingham Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/31/2017


      Ribometrix


      NC


      $7,500,000


      Seed


     

    Portfolio companies include:


      Alector
        web link


      Ribometrix
        web link


     

    Recent News: